COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 2652: Articles 26511-26520  | Next

Enantiomers of Chloroquine and Hydroxychloroquine Exhibit Different Activities Against SARS-CoV-2 in vitro, Evidencing S-Hydroxychloroquine as a Potentially Superior Drug for COVID-19
Li, G., Sun, J., Li, Y., Shi, Y., Zhao, J., Zhang, T. Y., Zhang, X.
10.1101/2020.05.26.114033 — Posted: 2020-05-27 Discussion: Onsite | Offsite
Assessment of sample pooling for clinical SARS-CoV-2 testing
St. George, K., Griesemer, S. B., Van Slyke, G.
10.1101/2020.05.26.118133 — Posted: 2020-05-27
Impact of Comorbidities on the Expression of SARS-CoV-2 Viral Entry-Related Genes
Breidenbach, J. D., Dube, P., Ghosh, S., Modyanov, N. N., Malhotra, D., Dworkin, L. D., Haller, S. T., Kennedy, D. J.
10.1101/2020.05.26.117440 — Posted: 2020-05-27
Different pattern of pre-existing SARS-COV-2 specific T cell immunity in SARS-recovered and uninfected individuals
Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M., Lin, M., Tan, N., Linster, M., Chia, W. N., Chen, M. I.-C., Wang, L.-F., Ooi, E. E., Kalimuddin, S., Tambyah, P. A., Low, J. G.-H., Tan, Y.-J., Bertoletti, A.
10.1101/2020.05.26.115832 — Posted: 2020-05-27 Discussion: Onsite | Offsite
Angiotensin-converting enzyme 2, a SARS-CoV-2 receptor, is upregulated by interleukin-6 via STAT3 signaling in rheumatoid synovium
Mokuda, S., Tokunaga, T., Masumoto, J., Sugiyama, E.
10.1101/2020.05.26.115261 — Posted: 2020-05-27 Discussion: Onsite | Offsite
Morphological Cell Profiling of SARS-CoV-2 Infection Identifies Drug Repurposing Candidates for COVID-19
Mirabelli, C., Wotring, J. W., Zhang, C. J., McCarty, S. M., Fursmidt, R., Kadambi, N. S., Amin, A. T., O'Meara, T. R., Pretto-Kernahan, C. D., Spence, J. R., Frum, T., Alysandratos, K. D., Huang, J., Kotton, D. N., Wobus, C. E., Weatherwax, K. J., Mashour, G. A., Handelman, S. K., O'Meara, M. J., Sexton, J. Z.
10.1101/2020.05.27.117184 — Posted: 2020-05-27 Discussion: Offsite
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
Douangamath, A., Fearon, D., Gehrtz, P., Krojer, T., Lukacik, P., Owen, C. D., Resnick, E., Strain-Damerell, C., aimon, A., Abranyi-Balogh, P., Brandao-Neto, J., Carberry, A., Davison, G., Dias, A., Downes, T. D., Dunnett, L., Fairhead, M., Firth, J. D., Jones, S. P., Keely, A., Keserü, G. M., Klein, H. F., Martin, M. P., Noble, M. E. M., O'Brien, P., Powell, A., Reddi, R., Skyner, R., Snee, M., Waring, M. J., Wild, C., London, N., von Delft, F., Walsh, M. A.
10.1101/2020.05.27.118117 — Posted: 2020-05-27
Finding disease modules for cancer and COVID-19 in gene co-expression networks with the Core&Peel method
Lucchetta, M., Pellegrini, M.
10.1101/2020.05.27.118414 — Posted: 2020-05-27
Development and validation of IMMUNO-COV: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2
Vandergaast, R., Carey, T., Reiter, S., Lech, P., Gnanadurai, C., Tesfay, M., Buehler, J., Suksanpaisan, L., Naik, S., Brunton, B., Recker, J., Haselton, M., Ziegler, C., Roesler, A., Mills, J. R., Theel, E., Weaver, S. C., Rafael, G., Roforth, M. M., Jerde, C., Tran, S., Diaz, R. M., Bexon, A., Baum, A., Kyratsous, C. A., Peng, K.-W., Russell, S. J.
10.1101/2020.05.26.117549 — Posted: 2020-05-27 Discussion: Onsite
Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
Goldman-Israelow, B., Song, E., Mao, T., Lu, P., Meir, A., Liu, F., Madel Alfajaro, M., Wei, J., Dong, H., Homer, R., Ring, A., Wilen, C. B., Iwasaki, A.
10.1101/2020.05.27.118893 — Posted: 2020-05-27 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).